Quadrant Capital Group LLC Ascendis Pharma A/S Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Quadrant Capital Group LLC holds 335 shares of ASND stock, worth $41,633. This represents 0.0% of its overall portfolio holdings.

Number of Shares

335

Previous 342 2.05%

Holding current value

$41,633

Previous $46,000 8.7%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$113.0 - $153.43 $791 - $1,074	-7 Reduced 2.05%	335 $50,000
Q2 2024 Aug 12, 2024	BUY	$121.07 - $153.67 $1,331 - $1,690	11 Added 3.32%	342 $46,000
Q1 2024 May 15, 2024	BUY	$123.45 - $159.4 $1,604 - $2,072	13 Added 4.09%	331 $50,000
Q4 2023 Feb 08, 2024	BUY	$86.1 - $127.36 $13,001 - $19,231	151 Added 90.42%	318 $40,000
Q3 2023 Nov 14, 2023	SELL	$86.5 - $103.97 $2,508 - $3,015	-29 Reduced 14.8%	167 $15,000
Q2 2023 Aug 09, 2023	SELL	$69.96 - $97.84 $5,806 - $8,120	-83 Reduced 29.75%	196 $17,000
Q1 2023 May 11, 2023	SELL	$104.9 - $126.78 $7,447 - $9,001	-71 Reduced 20.29%	279 $29,000
Q4 2022 Feb 10, 2023	BUY	$99.42 - $131.97 $7,058 - $9,369	71 Added 25.45%	350 $42,000
Q3 2022 Nov 10, 2022	BUY	$84.03 - $110.23 $8,739 - $11,463	104 Added 59.43%	279 $29,000
Q2 2022 Aug 09, 2022	SELL	$78.08 - $117.61 $2,342 - $3,528	-30 Reduced 14.63%	175 $16,000
Q1 2022 May 06, 2022	SELL	$102.18 - $135.75 $6,028 - $8,009	-59 Reduced 22.35%	205 $24,000
Q4 2021 Feb 01, 2022	BUY	$127.1 - $169.66 $6,482 - $8,652	51 Added 23.94%	264 $36,000
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $4,619 - $7,253	41 Added 23.84%	213 $34,000
Q2 2021 Aug 09, 2021	BUY	$121.62 - $145.29 $12,405 - $14,819	102 Added 145.71%	172 $23,000
Q1 2021 May 12, 2021	BUY	$124.92 - $173.33 $3,247 - $4,506	26 Added 59.09%	70 $9,000
Q4 2020 Feb 16, 2021	BUY	$151.2 - $182.76 $2,570 - $3,106	17 Added 62.96%	44 $7,000
Q3 2020 Nov 13, 2020	BUY	$134.29 - $154.32 $134 - $154	1 Added 3.85%	27 $4,000
Q2 2020 Aug 13, 2020	BUY	$110.87 - $156.01 $2,882 - $4,056	26 New	26 $4,000

Others Institutions Holding ASND

# of Institutions

236

Shares Held

58.2M

Call Options Held

238K

Put Options Held

299K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $6.94B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Ascendis Pharma A/S Transaction History